Intravenous thrombolysis for patients with ischaemic stroke on antiplatelet therapy: a blessing in disguise?

Eur J Neurol. 2010 Feb;17(2):177-8. doi: 10.1111/j.1468-1331.2009.02851.x. Epub 2009 Nov 18.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Brain Ischemia / complications
  • Brain Ischemia / drug therapy*
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk
  • Stroke / complications
  • Stroke / drug therapy*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Tissue Plasminogen Activator